Personalized neoantigen DNA vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Personalized neoantigen DNA vaccine, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma [Phase 1]